Skip to main content
ARS Home » Pacific West Area » Pullman, Washington » Animal Disease Research » Research » Publications at this Location » Publication #391834

Research Project: Identifying Effective Immune Responses and Vaccine Development for Bovine Anaplasmosis

Location: Animal Disease Research

Title: Anaplasma marginale infection of Dermacentor andersoni primary midgut cell culture is dependent on fucosylated glycans

Author
item VIMONISH, RUBIKAH - Washington State University
item CAPELLI-PEIXOTO, JANAINA - Washington State University
item JOHNSON, WENDELL - Retired ARS Employee
item HUSSEIN, HALA - Washington State University
item Taus, Naomi
item BRAYTON, KELLY - Washington State University
item MUNDERLOH, ULRIKE - University Of Minnesota
item Noh, Susan
item Ueti, Massaro

Submitted to: Frontiers in Cellular and Infection Microbiology
Publication Type: Peer Reviewed Journal
Publication Acceptance Date: 5/6/2022
Publication Date: 5/31/2022
Citation: Vimonish, R., Capelli-Peixoto, J., Johnson, W.C., Hussein, H.E., Taus, N.S., Brayton, K.A., Munderloh, U.G., Noh, S.M., Ueti, M.W. 2022. Anaplasma marginale infection of Dermacentor andersoni primary midgut cell culture is dependent on fucosylated glycans. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2022.877525.
DOI: https://doi.org/10.3389/fcimb.2022.877525

Interpretive Summary: Tick midgut is the primary infection site required by the tick-borne pathogens to initiate their development for transmission. Despite the biological significance of this organ, cell cultures from midgut tissues are unavailable. To study the mechanism of Anaplasma marginale-tick cell interactions, we successfully developed an in vitro Dermacentor andersoni primary midgut cell culture system. Midgut cells were maintained for up to 120 days. We demonstrated the infection of in vitro midgut cells by using mCherry transfected A. marginale with continued replication for up to 10 days post-infection. Anaplasma marginale infection of midgut cells regulated the differential expression of tick a-(1,3)-fucosyltransferases A1 and A2. Silencing of a-(1,3)-fucosyltransferase A2 in uninfected midgut cells reduced the display of fucosylated glycans and significantly lowered the susceptibility of midgut cells for A. marginale infection, suggesting that the pathogen utilizes core a-(1,3)-fucose of N-glycans to infect tick midgut cells. This is the first report using in vitro primary D. andersoni midgut cells to study A. marginale-tick cell interactions at the molecular level. The primary midgut cell culture system will further facilitate the investigation of tick-pathogen interactions, leading to the development of novel intervention strategies for tick-borne diseases.

Technical Abstract: Tick midgut is the primary infection site required by the tick-borne pathogens to initiate their development for transmission. Despite the biological significance of this organ, cell cultures from midgut tissues are unavailable. To study the mechanism of Anaplasma marginale-tick cell interactions, we successfully developed an in vitro Dermacentor andersoni primary midgut cell culture system. Midgut cells were maintained for up to 120 days. We demonstrated the infection of in vitro midgut cells by using mCherry transfected A. marginale with continued replication for up to 10 days post-infection. Anaplasma marginale infection of midgut cells regulated the differential expression of tick a-(1,3)-fucosyltransferases A1 and A2. Silencing of a-(1,3)-fucosyltransferase A2 in uninfected midgut cells reduced the display of fucosylated glycans and significantly lowered the susceptibility of midgut cells for A. marginale infection, suggesting that the pathogen utilizes core a-(1,3)-fucose of N-glycans to infect tick midgut cells. This is the first report using in vitro primary D. andersoni midgut cells to study A. marginale-tick cell interactions at the molecular level. The primary midgut cell culture system will further facilitate the investigation of tick-pathogen interactions, leading to the development of novel intervention strategies for tick-borne diseases.